✦ LIBER ✦

Treatment with low-dose oral etoposide in patients with myelodysplastic syndromes

✍ Scribed by Donald C. Doll; Lawrence M. Kasper; Raymond Taetle; Alan F. List

Book ID: 114119167
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 560 KB
Volume: 22
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(97)00149-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of myelodysplastic syndromes w

Treatment of myelodysplastic syndromes with low-dose oral 6-thioguanine

✍ Spitzer, Thomas R. ;Lazarus, Hillard M. ;Crum, Edward D. ;Weisman, Russell 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

Several cytotoxic agents when used in vitro in very low concentrations have been shown to induce differentiation of leukemic cells. We treated 18 patients with rnyelodysplastic syndromes with lowdose oral 6-thioguanine (6-TG; 20 to 60 rng daily). Four patients demonstrated significant improvement in

Successful treatment with a low-dose cis

Successful treatment with a low-dose cisplatin–etoposide regimen for patients with diencephalic syndrome

✍ Iacopo Sardi, Cecilia Bresci, Elisabetta Schiavello, Veronica Biassoni, Valentin 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 588 KB

Sustained haematological response to hig

Sustained haematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes

✍ Kelsey, S.M.; Newland, A.C.; Cunningham, J.; Makin, H.L.J.; Coldwell, R.D.; Mill 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 320 KB

Treatment of acute leukemia arising from

Treatment of acute leukemia arising from myelodysplastic syndromes with oral idarubicin, etoposide, and 6-thioguanine

✍ M. Montillo; A. Tedeschi; A. Olivieri; R. Centurioni; G. Pelliccia; G. Marchegia 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Treatment of myelodysplastic syndrome an

Treatment of myelodysplastic syndrome and atypical leukemia with low-dose aclarubicin

✍ Tsunefumi Shibuya; Takanori Teshima; Mine Harada; Shuichi Taniguchi; Takashi Oka 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Treatment of low-risk myelodysplastic sy

Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000–4000 IU vitamin D3)

✍ Molnár, I; Stark, N; Lovato, J; Powell, B L; Cruz, J; Hurd, D D; Mathieu, J S; C 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB